Agreed in moderation, but she has a 2 in 3 chance of having received Leronlimab and she is entrepreneurial enough to have her own youtube channel, if the primary driver is attention, profit, or other I couldn't say, still she's drawing more attention to Cytodyn and what ever her actual treatment was as long as the trial meets expectations, the attention is a positive, in my opinion.
News 
Market Data 
Discover 
AI
